Beta Blockers May Cause Depressive Symptoms
Beta-blocker treatment can lead to a modest increase in depressive symptoms among patients who have myocardial infarction with preserved LVEF.
Related Articles
Trump picks Johns Hopkins surgeon Makary to run FDA
Makary is a close ally of Robert F. Kennedy Jr. and a proponent of his “Make America Healthy Again” movement to fight chronic diseases.
Attruby™ (acoramidis) Is Now Approved – Learn More
ATTRuby™ (acoramidis) is now approved. Access the medication guide, prescribing information, and patient support services offered through ForgingBridges
Two‐Stage Recruitment Design to Reduce Magnetic Resonance Imaging Screening Cost for a Theoretical Clinical Trial of White Matter Hyperintensity Progression | Journal of the American Heart Association
BackgroundWhite matter hyperintensities (WMH) and their progression are associated with risk of dementia and stroke, so are an important target for clinical trials. The cost…
Associations of Neighborhood Food and Physical Activity Environments in Young Adulthood With Cardiovascular Health in Midlife: The CARDIA Study | Journal of the American Heart Association
BackgroundAdults who maintain ideal cardiovascular health (CVH) profiles up to midlife have lower risk of several chronic diseases and better quality of life. Some evidence…
Trump picks Johns Hopkins surgeon Makary to run FDA
Makary is a close ally of Robert F. Kennedy Jr. and a proponent of his “Make America Healthy Again” movement to fight chronic diseases.
BridgeBio wins FDA approval for heart disease drug
The FDA approved a new medicine from BridgeBio for patients with ATTR-CM, a progressive heart disease
Post-Ablation cardiac Magnetic resonance to assess Ventricular Tachycardia recurrence (PAM-VT study)
AbstractAims. Conducting channels (CCs) detected by late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) are related to ventricular tachycardia
Alterations in circulating measures of Th2 immune responses pre-lung transplant associates with reduced primary graft dysfunction
Primary graft dysfunction (PGD) is a complication of lung transplantation that continues to cause significant morbidity. The Th2 immune response has been shown to counteract…
Bleeding Risk Using NSAIDs With Anticoagulants After VTE – American College of Cardiology
Geoffrey D. Barnes, MD, MSc, FACC
PGC Genomics Scientific Retreat | Duke University School of Medicine
The fourth annual Precision Genomics Collaboratory Retreat will be held on December 13, 2024. This is a day-long event in the Trent Semans Center Great…
